Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal Ruchika Sharma3 Jan 2024 9:00 AM ISTAccording to Oppenheimer, Moderna could have five products on the market by 2026.
AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China Ruchika Sharma2 Jan 2024 3:06 PM ISTChina: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...
Hyderabad: Spurious drugs racket busted, Rs 26 lakh stocks seized Ruchika Sharma2 Jan 2024 1:30 PM ISTSpurious/counterfeit drugs detected and seized by DCA officials include fake medicines which are falsely labeled under the names of reputed companies...
Airport Metro, Pharma City projects not scrapped: Telangana CM Ruchika Sharma2 Jan 2024 11:50 AM ISTHyderabad: Telangana Chief Minister A. Revanth Reddy on Monday clarified that the state government has not scrapped the Airport Metro and Pharma...
CDSCO panel Approves Pfizer's Protocol Amendment Proposal for Anti-cancer Drug Elranatamab Dr. Divya Colin2 Jan 2024 5:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves AstraZeneca's Proposal for Protocol Amendment of anti-cancer drug Asciminib Dr. Divya Colin2 Jan 2024 5:30 AM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Justify Clinical Relevance of Higher Strength of Caroverine Capsules: CDSCO Panel Tells Lincoln Pharma Dr. Divya Colin1 Jan 2024 5:30 PM ISTNew Delhi: Noting that proposed higher strength of Caroverine Capsules (40mg) is not approved anywhere in the world, the Subject Expert Committee...
CDSCO Panel Approves Pfizer's Proposal for protocol amendment of Marstacimab Dr. Divya Colin1 Jan 2024 5:30 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Nephrocare India raises Rs 8.08 crore in pre-IPO round Ruchika Sharma1 Jan 2024 1:10 PM ISTThe fresh infusion of capital will fuel Nephrocare India's target of establishing 22 high-end kidney care facilities across India by March 2026.
Reckitt's Mead Johnson Nutrition recalls baby formula powder from US Ruchika Sharma1 Jan 2024 12:12 PM ISTReckitt Benckiser Group's Mead Johnson Nutrition (MJN) is voluntarily recalling select batches of Nutramigen Powder from the U.S. market due to a...
CDSCO Panel Grants Novartis Protocol Amendment For Ofatumumab Dr. Divya Colin31 Dec 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Modify eGFR value as per standard guidelines: CDSCO Panel Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin31 Dec 2023 5:15 PM ISTNew Delhi: Reviewing the drug major Hetero Lab's revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin...
